down arrow

Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
305.00
8.1 (2.73%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Sun Pharma.Inds.
Torrent Pharma
Venus Remedies
Lyka Labs
Zenotech Lab.
SMS Lifesciences
Brooks Lab.
Mankind Pharma
Infinium Pharma
Why is Venus Remedies Ltd ?
1
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 4.81% returns since then
  • The stocks MACD and Bollinger Band technical factors are also Bearish
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Venus Remedies for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Venus Remedies
-10.02%
-0.21
48.24%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.19%
EBIT Growth (5y)
98.02%
EBIT to Interest (avg)
19.23
Debt to EBITDA (avg)
1.14
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.11
Tax Ratio
40.20%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.11%
ROCE (avg)
5.41%
ROE (avg)
6.04%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
33
Price to Book Value
0.80
EV to EBIT
10.02
EV to EBITDA
5.62
EV to Capital Employed
0.76
EV to Sales
0.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.70%
ROE (Latest)
4.47%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
PBT LESS OI(Q)

At Rs 12.94 cr has Grown at 138.31 %

CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 78.43 cr

NET SALES(Q)

At Rs 176.86 cr has Grown at 23.32 %

OPERATING PROFIT TO NET SALES(Q)

Highest at 10.38%

PAT(Q)

Highest at Rs 11.79 cr.

EPS(Q)

Highest at Rs 14.66

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Venus Remedies
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 12.94 cr has Grown at 138.31 %
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 11.79 cr has Grown at 72.2 %
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 176.86 cr has Grown at 23.32 %
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 10.38%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit After Tax (PAT) - Quarterly
Highest at Rs 11.79 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 14.66
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Cash and Cash Equivalents - Half Yearly
Highest at Rs 78.43 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents